191 related articles for article (PubMed ID: 1705994)
1. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.
Kodama T; Burns DP; Silva DP; Veronese FD; Desrosiers RC
J Virol; 1991 Apr; 65(4):2010-8. PubMed ID: 1705994
[TBL] [Abstract][Full Text] [Related]
2. Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
Postler TS; Martinez-Navio JM; Yuste E; Desrosiers RC
J Virol; 2012 Jan; 86(2):1145-57. PubMed ID: 22072749
[TBL] [Abstract][Full Text] [Related]
3. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
[TBL] [Abstract][Full Text] [Related]
4. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
Shacklett BL; Shaw KE; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA
J Virol; 2002 Nov; 76(22):11365-78. PubMed ID: 12388697
[TBL] [Abstract][Full Text] [Related]
5. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.
Torres JV; Malley A; Banapour B; Anderson DE; Axthelm MK; Gardner MB; Benjamini E
AIDS Res Hum Retroviruses; 1993 May; 9(5):423-30. PubMed ID: 7686386
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
Yuste E; Bixby J; Lifson J; Sato S; Johnson W; Desrosiers R
J Virol; 2008 Dec; 82(24):12472-86. PubMed ID: 18829751
[TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.
Burns DP; Collignon C; Desrosiers RC
J Virol; 1993 Jul; 67(7):4104-13. PubMed ID: 8510218
[TBL] [Abstract][Full Text] [Related]
8. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys.
Yasutomi Y; McAdam SN; Boyson JE; Piekarczyk MS; Watkins DI; Letvin NL
J Immunol; 1995 Mar; 154(5):2516-22. PubMed ID: 7532670
[TBL] [Abstract][Full Text] [Related]
9. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
Stahl-Hennig C; Voss G; Dittmer U; Coulibaly C; Petry H; Makoschey B; Cranage MP; Aubertin AM; Lüke W; Hunsmann G
AIDS; 1993 Jun; 7(6):787-95. PubMed ID: 8363756
[TBL] [Abstract][Full Text] [Related]
10. Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.
Jurkiewicz E; Hunsmann G; Schäffner J; Nisslein T; Lüke W; Petry H
J Virol; 1997 Dec; 71(12):9475-81. PubMed ID: 9371609
[TBL] [Abstract][Full Text] [Related]
11. The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.
Kirchhoff F; Mori K; Desrosiers RC
J Virol; 1994 Jun; 68(6):3682-92. PubMed ID: 8189506
[TBL] [Abstract][Full Text] [Related]
12. The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine.
Cranage MP; McBride BW; Rud EW
Vaccine; 1995 Jul; 13(10):895-900. PubMed ID: 7483761
[TBL] [Abstract][Full Text] [Related]
13. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.
Shacklett BL; Weber CJ; Shaw KE; Keddie EM; Gardner MB; Sonigo P; Luciw PA
J Virol; 2000 Jul; 74(13):5836-44. PubMed ID: 10846063
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.
Matsumi S; Matsushita S; Yoshimura K; Javaherian K; Takatsuki K
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):501-8. PubMed ID: 7632464
[TBL] [Abstract][Full Text] [Related]
15. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys.
Burns DP; Desrosiers RC
J Virol; 1991 Apr; 65(4):1843-54. PubMed ID: 2002545
[TBL] [Abstract][Full Text] [Related]
16. SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.
Torres JV; Anderson DE; Malley A; Banapour B; Axthelm MK; Benjamini E; Gardner MB
J Med Primatol; 1993; 22(2-3):129-37. PubMed ID: 7692056
[TBL] [Abstract][Full Text] [Related]
17. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
Chackerian B; Rudensey LM; Overbaugh J
J Virol; 1997 Oct; 71(10):7719-27. PubMed ID: 9311856
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation of the SIVagm transmembrane glycoprotein in naturally and experimentally infected primates.
Fomsgaard A; Johnson PR; London WT; Hirsch VM
AIDS; 1993 Aug; 7(8):1041-7. PubMed ID: 8397939
[TBL] [Abstract][Full Text] [Related]
19. Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey.
Igarashi T; Kuwata T; Takehisa J; Ibuki K; Shibata R; Mukai R; Komatsu T; Adachi A; Ido E; Hayami M
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1649-58. PubMed ID: 8760411
[TBL] [Abstract][Full Text] [Related]
20. Autologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys.
Yeh WW; Rahman I; Hraber P; Coffey RT; Nevidomskyte D; Giri A; Asmal M; Miljkovic S; Daniels M; Whitney JB; Keele BF; Hahn BH; Korber BT; Shaw GM; Seaman MS; Letvin NL
J Virol; 2010 Jun; 84(12):6018-32. PubMed ID: 20357097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
